ロード中...
Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study
BACKGROUND: Pemetrexed and bevacizumab as monotherapies, or in combination, have been approved for maintenance therapy following platinum‐based induction in patients with advanced nonsquamous non‐small cell lung cancer (NSCLC). The differences in the benefits of bevacizumab for treatment during earl...
保存先:
| 出版年: | Thorac Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons Australia, Ltd
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7327679/ https://ncbi.nlm.nih.gov/pubmed/32406994 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13469 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|